📌 Key Takeaways
- Topic: Silica Matting Agent: How It Works, Key Specs and How to Choose the Right Grade
- Keywords: buy silica powder
- Published: 2026-11-20 06:49:13
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Filler for CCL: How It Improves Copper Clad Laminate Performance
- Silica for Skincare: Benefits for Oil Control, Texture and Soft-Focus Effects
- Yao, X. et al. Graphene quantum dots‐capped magnetic mesoporous silica nanoparticles as a multifunctional platform for controlled drug delivery, magnetic hyperthermia, and photothermal therapy. Tiny 13, 1602225 (2017). Piece Google Scholar
- Silica for Feed Carrier: How It Carries Vitamins and Liquids in Animal Feed
- Silica Nanoparticles: Synthesis, Properties, Safety and Applications
- Silica for HPLC: Particle Types, Pore Sizes and Column Performance
What Is Hydrated Silica? Uses in Toothpaste, Cosmetics and Food Explained
What is silica (SiO₂)?
silica food additive Zhao, P., Li, H. & Bu, W. A forward vision for chemodynamic therapy: Issues and chances. Angew. Chem. Int. Ed. 62, e202210415 (2023). Article CAS Google Scholar
What is the difference between fumed silica and precipitated silica?
silica supplier Brazil
What drives silica raw material prices?
silica supplier Indonesia For metal sulfide NPs/MSNs nanocomposites, the small-sized CdS NPs as a gatekeeper is the first example of MSNs-based therapeutic system for controlled drug delivery, reported in 2003. 51 Other metal sulfides such as copper sulfide (CuS), molybdenum disulfide (MoS 2 ) and bismuth sulfide (Bi 2 S 3 ) exhibit high NIR absorption coefficients in the NIR region owing to their plasmon resonance effect or electron-hole generation and relaxation mechanism, 182, 183, 184, 185, 186 and consequently those metal sulfides NPs can serve as potential photothermal agents. For instance, hollow MSNs functionalized with chitosan were synthesized, and then loaded with CuS nanodots. The CuS nanodots could act as a gatekeeper to seal the surface pores of MSNs, leading to the controllable release of DOX. The as-resulted CuS/MSNs-based therapeutic nanoplatform, with the photothermal conversion efficiency being 36.4%, dramatically extended the survival rate of tumor-bearing mice by the photothermal-enhanced synergistic therapy. 162 Similarly, in another study, the MoS 2 nanosheets with brilliant photothermal conversion capacity were also used as a capping agent to block MSNs to realize the drug release. Experimental results demonstrated that the MoS 2 /MSNs nanocomposite has the capability of pH-dependent and photothermal-triggered DOX release, consequently achieving the targeted tumor killing by the combination of chemotherapy and PTT. 187
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.